Search

Search Constraints

You searched for: Author/Creator Wardelmann, Eva

Search Results

1. 90Y‐ibritumomab‐tiuxetan as a therapeutic alternative for follicular lymphoma (FL): A single‐center experience. (3rd September 2018)

2. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma – An analysis of the EORTC 62012 study of the EORTC STBSG. (September 2016)

3. Activating mutations in the MAP‐kinase pathway define non‐ossifying fibroma of bone. Issue 1 (24th January 2019)

4. Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'. (July 2020)

5. Alveolar rhabdomyosarcoma confined to the bone marrow with no identifiable primary tumour using FDG-PET/CT. Issue 1 (December 2015)

6. Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K). (28th January 2017)

7. CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer. (November 2017)

8. Characterization of the Genetic Program Linked to the Development of Atrial Fibrillation in CREM-IbΔC-X Mice. (August 2017)

10. Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study. (January 2023)